These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 21172161)

  • 1. [Study on the value of tumor markers ProGRP, CYFRA21-1, NSE and CEA in the differential diagnosis of pleural effusion].
    Liu Y; Yu L; Lin J
    Zhongguo Fei Ai Za Zhi; 2006 Jun; 9(3):273-6. PubMed ID: 21172161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of tumor markers in distinguishing lung adenocarcinoma-associated malignant pleural effusion from tuberculous pleural effusion.
    Ai L; Wang W; Li J; Ye T; Li Y
    Am J Med Sci; 2024 Apr; ():. PubMed ID: 38583522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application Value of CYFRA21-1 Combined with NSE, CEA, and SCC-Ag in Lung Cancer.
    Fu Y; Li D; Zhu Y; Yan S; Wang X; Lian Z; Xie Q; He Z
    Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations.
    Trulson I; Klawonn F; von Pawel J; Holdenrieder S
    Tumour Biol; 2024; 46(s1):S81-S98. PubMed ID: 38277317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and Their Relationship with CT Signs.
    Tian K; Li Z; Qin L
    Biomed Res Int; 2022; 2022():4119912. PubMed ID: 35937401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum tumor markers combined with dual-source CT in the diagnosis of lung cancer.
    Shan Y; Yin X; Zhao N; Wang J; Yang S
    Minerva Med; 2023 Dec; 114(6):795-801. PubMed ID: 33764713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the application value of pro-gastrin-releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma.
    Miao Q; Lv X; Luo L; Zhang J; Cai B
    Cancer Med; 2023 Oct; 12(19):19576-19582. PubMed ID: 37754747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Value of Pleural Effusion and Serum MMP-3 and CYFRA21-1 Combined with ADA in Differential Diagnosis of Pleural Exudative Effusion.
    Xu Z; Guan J; Xu J; Tu J; Cheng J
    Emerg Med Int; 2022; 2022():1615058. PubMed ID: 36072615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic values of conventional tumor markers and their combination with chest CT for patients with stageⅠA lung cancer].
    Peng Q; Wu N; Huang Y; Zhao SJ; Tang W; Liang M; Ran YL; Xiao T; Yang L; Liang X
    Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):934-941. PubMed ID: 37968078
    [No Abstract]   [Full Text] [Related]  

  • 10. Human epididymal protein 4 and its combined detection show good diagnostic value in lung cancer: A retrospective study.
    Wu L; Chen X; Peng T; Tang E; Bai W; Chen L
    Int J Biol Markers; 2024 Jun; 39(2):141-148. PubMed ID: 38619974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of combined detection of Carcinoembryonic Antigen and CA125 in the diagnosis of non-small cell lung cancer combined with Malignant Pleural Effusion.
    Yan W; Li Y; Peng Z
    Pak J Med Sci; 2024; 40(5):995-1000. PubMed ID: 38827875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing Diagnostic Accuracy for Lung Cancer through Combined Detection of Multiple Tumor Markers.
    Qing G; Jiang X; Xu G; Liu T; Deng T
    Altern Ther Health Med; 2023 Nov; 29(8):36-41. PubMed ID: 37632966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum CEA, CYFRA-211, and NSE as Diagnostic Biomarkers for Bone Metastasis in Lung Cancer.
    Duan X; Yan Y; Tai Y; Fan R
    Altern Ther Health Med; 2024 Jun; ():. PubMed ID: 38904626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple and efficient clinical prediction scoring system to identify malignant pleural effusion.
    Wang S; An J; Hu X; Zeng T; Li P; Qin J; Shen Y; Wang T; Wen F
    Ther Adv Respir Dis; 2024; 18():17534666231223002. PubMed ID: 38189181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Value of Imaging Combined With Tumor Markers in Early Detection of Lung Cancer.
    Wei SJ; Wang LP; Wang JY; Ma JX; Chuan FB; Zhang YD
    Front Surg; 2021; 8():694210. PubMed ID: 34901134
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel.
    Izawa A; Hara Y; Horita N; Muraoka S; Kaneko M; Kaneko A; Somekawa K; Hirata M; Otsu Y; Matsumoto H; Nagasawa R; Tanaka K; Kubo S; Murohashi K; Aoki A; Fujii H; Watanabe K; Kobayashi N; Miura K; Nakajima H; Kaneko T
    Transl Lung Cancer Res; 2024 Mar; 13(3):503-511. PubMed ID: 38601457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of PD-1/PD-L1 Inhibitor and Chemotherapy in Treatment of Advanced Small Cell Lung Cancer.
    Tian W; Zhao J; Wang W; Li Y
    Altern Ther Health Med; 2023 Nov; ():. PubMed ID: 37971453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Usefulness of the Ratio of Antigen-Autoantibody Immune Complexes to Their Free Antigens in the Diagnosis of Non-Small Cell Lung Cancer.
    Kim H; Lee JK; Oh AC; Kim HR; Hong YJ
    Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of influencing factors of serum SCCA elevation in 309 CAP patients with normal CEA,NSE and CYFRA21-1.
    Wang J; Tang X; Liu X; Zhang J
    Front Oncol; 2024; 14():1243432. PubMed ID: 38347831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Diagnosis of Malignant Pleural Effusion Using Tumor-Marker Combinations: A Cost-Effectiveness Analysis Based on a Stacking Model.
    Wang J; Zhou J; Wu H; Chen Y; Liang B
    Diagnostics (Basel); 2023 Oct; 13(19):. PubMed ID: 37835879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.